JohnHIpMD
Cardiology • Lansing, MIAdult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Director, Sparrow Clinical Research Institute
Dr. Ip is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1140 E Michigan Ave
Ste 400
Lansing, MI 48912Phone+1 517-364-9650Fax+1 517-364-9605
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 1988 - 1990
NYU Grossman School of MedicineResidency, Internal Medicine, 1985 - 1988
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1985
Certifications & Licensure
MI State Medical License 1992 - 2026
NY State Medical License 1986 - 1994- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk Start of enrollment: 2008 Feb 01
- Implanted Loop Recorder Post Atrial Fibrillation Ablation Start of enrollment: 2008 Aug 01
- Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study Start of enrollment: 2018 May 18
Publications & Presentations
PubMed
- 231 citationsVernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial.Denis Roy, Craig M. Pratt, Christian Torp-Pedersen, D. George Wyse, Egon Toft
Circulation. 2008-03-25 - 84 citationsMulticenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale...John Ip, Albert L. Waldo, Gregory Y.H. Lip, Peter M. Rothwell, David Martin
American Heart Journal. 2009-09-01 - 67 citationsStatin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and me...Michael G. Dickinson, John Ip, Brian Olshansky, Anne S. Hellkamp, Jill Anderson
American Heart Journal. 2007-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
